The ability to go wireless medically yields great gains, especially when used to help children with heart problems.
The Medical University of South Carolina is the first institution in the Southeast to implant pediatric patients with the Medtronic Reveal LINQ Insertable Cardiac Monitor System (REVEAL LINQ™ ICM) the smallest implantable cardiac monitoring device available.
Reveal LINQ ICM is approximately one-third the size of an AAA battery, roughly one cubic centimeter, making it more than 80 percent smaller than other implantable cardiac monitoring devices currently available and perfect-sized for pediatric patients. The device is part of a system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor.
MUSC pediatric cardiologist and assistant professor Nicole Cain, M.D., surgically implanted three of the devices in children last week, marking the first set of implant surgeries in the Southeast.
| ||Dr. Cain implants the device into Adam Mereby. He was one of the first patients in the Southeast to receive the wireless device.|
Placed just beneath the skin through a small incision of less than 1 centimeter in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device, available for children and adults, is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events.
The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias. The Reveal LINQ system also includes the new MyCareLink Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.